Making history: Thomas Francis, Jr, MD, and the 1954 Salk Poliomyelitis Vaccine Field Trial
- PMID: 10807305
- DOI: 10.1001/archpedi.154.5.512
Making history: Thomas Francis, Jr, MD, and the 1954 Salk Poliomyelitis Vaccine Field Trial
Abstract
This article focuses on the poliomyelitis vaccine field trial directed by Thomas Francis,Jr, MD, of the University of Michigan Vaccine Evaluation Center and sponsored by the National Foundation for Infantile Paralysis (NFIP) or, as it was better known to the public, the March of Dimes. It was a landmark in the widescale testing of a vaccine and the ethical use of human subjects. Millions of American parents readily volunteered their healthy children to participate. A total of 150,000 volunteers, including schoolteachers, physicians, nurses, and health officers all endorsed the study and donated their time and effort to make it successful. Avoiding the use of marginalized groups, the field trial purposefully did not involve institutionalized children; instead, it was based in 15,000 public schools in 44 of the 48 states as clinic sites. A group of 650,000 children received some type of injection, either the vaccine or a placebo, and another 1.18 million served as controls. The field trial depended, most essentially, on both public support and the participation of millions of children who remained enrolled in a study that required a series of 3 injections and a 6-month evaluation period. Enlisting the huge number of participants presented practical examples of the difficulties in experimenting on human subjects. On April 26, 1954, Randy Kerr, a participant or "Polio Pioneer" as the children involved were called, received the first inoculation of the Salk poliomyelitis vaccine. The nationwide study "designed to test the safety and efficacy" of the Salk vaccine had officially begun.
Similar articles
-
"A calculated risk": the Salk polio vaccine field trials of 1954.BMJ. 1998 Oct 31;317(7167):1233-6. doi: 10.1136/bmj.317.7167.1233. BMJ. 1998. PMID: 9794869 Free PMC article. No abstract available.
-
The Salk Polio Vaccine Trial of 1954: risks, randomization and public involvement in research.Clin Trials. 2004 Feb;1(1):122-30. doi: 10.1191/1740774504cn010xx. Clin Trials. 2004. PMID: 16281467
-
Suspended judgment. Remembering the role of Thomas Francis, Jr. in the design of the 1954 Salk Vaccine Trial.Control Clin Trials. 1992 Jun;13(3):181-4. doi: 10.1016/0197-2456(92)90001-g. Control Clin Trials. 1992. PMID: 1320555 No abstract available.
-
Francis field trial of inactivated poliomyelitis vaccine: background and lessons for today.Epidemiol Rev. 1999;21(1):7-23. doi: 10.1093/oxfordjournals.epirev.a017989. Epidemiol Rev. 1999. PMID: 10520470 Review. No abstract available.
-
A tale of two vaccines: lessons from polio that could inform the development of an HIV vaccine.AIDS. 2013 Jan 2;27(1):1-5. doi: 10.1097/QAD.0b013e328359f2c1. AIDS. 2013. PMID: 23018439 Review.
Cited by
-
Matrix and backstage: cellular substrates for viral vaccines.Viruses. 2014 Apr 11;6(4):1672-700. doi: 10.3390/v6041672. Viruses. 2014. PMID: 24732259 Free PMC article. Review.
-
Evaluating the Effectiveness of Vaccines Using a Regression Discontinuity Design.Am J Epidemiol. 2019 Jun 1;188(6):987-990. doi: 10.1093/aje/kwz043. Am J Epidemiol. 2019. PMID: 30976806 Free PMC article.
-
Evidence-based public health: moving beyond randomized trials.Am J Public Health. 2004 Mar;94(3):400-5. doi: 10.2105/ajph.94.3.400. Am J Public Health. 2004. PMID: 14998803 Free PMC article.
-
Effect of maternal antibody on the infant immune response to inactivated poliovirus vaccines made from Sabin strains.Hum Vaccin Immunother. 2019;15(5):1160-1166. doi: 10.1080/21645515.2019.1572410. Epub 2019 Mar 19. Hum Vaccin Immunother. 2019. PMID: 30676838 Free PMC article. Clinical Trial.
-
Large Simple Double-Blind Randomized Trials for the Rapid Assessment of the Effectiveness of COVID-19 Vaccines.J Infect Dis. 2020 Oct 1;222(9):1571-1572. doi: 10.1093/infdis/jiaa456. J Infect Dis. 2020. PMID: 32845317 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Personal name as subject
- Actions
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous